CSD201203: A Study to Determine Subject Puffing Patterns of a Non-cylindrical, Closed, Electronic Nicotine Delivery System at Three Nicotine Concentrations in an Ambulatory Setting

NCT05118139 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2025-04-10

No results posted yet for this study

Summary

This is a multi-center, open-label, parallel, three-study-group investigation to evaluate the puffing patterns of healthy adult consumers of tobacco products switching from a usual brand (UB) Electronic Nicotine Delivery Systems (ENDS) product to the ENDS Investigational Product (IP), over a 9-day ambulatory period.

Conditions

  • Smoking
  • Tobacco Use
  • Electronic Cigarette Use

Interventions

OTHER

P1211216

Flavor variant P1211216 of a 1.5% nicotine ENDS product

OTHER

P1213416

Flavor variant P1213416 of a 1.5% nicotine ENDS product

OTHER

P1213716

Flavor variant P1213716 of a 1.5% nicotine ENDS product

OTHER

P1213616

Flavor variant P1213616 of a 1.5% nicotine ENDS product

OTHER

P1213816

Flavor variant P1213816 of a 1.5% nicotine ENDS product

OTHER

P1211916

Flavor variant P1211916 of a 1.5% nicotine ENDS product

OTHER

P1210016

Flavor variant P1210016 of a 1.5% nicotine ENDS product

OTHER

P1211217

Flavor variant P1211217 of a 2.4% nicotine ENDS product

OTHER

P1213417

Flavor variant P1213417 of a 2.4% nicotine ENDS product

OTHER

P1211222

Flavor variant P1211222 of a 5% nicotine ENDS product

OTHER

P1213422

Flavor variant P1213422 of a 5% nicotine ENDS product

OTHER

P1213722

Flavor variant P1213722 of a 5% nicotine ENDS product

OTHER

P1213622

Flavor variant P1213622 of a 5% nicotine ENDS product

OTHER

P1213822

Flavor variant P1213822 of a 5% nicotine ENDS product

OTHER

P1211922

Flavor variant P1211922 of a 5% nicotine ENDS product

OTHER

P1210022

Flavor variant P1210022 of a 5% nicotine ENDS product

Sponsors & Collaborators

  • RAI Services Company

    lead INDUSTRY

Principal Investigators

  • Gary Dull, PhD · RAIS

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-11
Primary Completion
2022-07-30
Completion
2022-07-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05118139 on ClinicalTrials.gov